344 related articles for article (PubMed ID: 27435523)
1. Two infants with tuberculid associated with Kawasaki disease.
Yamada H; Ohta H; Hasegawa S; Azuma Y; Hasegawa M; Kadoya R; Ohbuchi N; Ohnishi Y; Okada S; Hoshide M; Ohga S
Hum Vaccin Immunother; 2016 Nov; 12(11):2772-2776. PubMed ID: 27435523
[TBL] [Abstract][Full Text] [Related]
2. BCG and Kawasaki disease in Mexico and Japan.
Gamez-Gonzalez LB; Hamada H; Llamas-Guillen BA; Ruiz-Fernandez M; Yamazaki-Nakashimada M
Hum Vaccin Immunother; 2017 May; 13(5):1091-1093. PubMed ID: 28281896
[TBL] [Abstract][Full Text] [Related]
3. Papulonecrotic tuberculid after Bacillus Calmette-Guérin (BCG) vaccination with lung infiltration that mimics disseminated BCG infection.
Miyamura T; Egashira S; Yoshino Y; Sawatari M; Nishihara T; Ihn H
J Dermatol; 2019 Aug; 46(8):e267-e268. PubMed ID: 30811058
[No Abstract] [Full Text] [Related]
4. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guérin inoculation site.
Uehara R; Igarashi H; Yashiro M; Nakamura Y; Yanagawa H
Pediatr Infect Dis J; 2010 May; 29(5):430-3. PubMed ID: 20032807
[TBL] [Abstract][Full Text] [Related]
5. Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.
Loh ACE; Kua PHJ; Tan ZL
Singapore Med J; 2019 Feb; 60(2):89-93. PubMed ID: 30009317
[TBL] [Abstract][Full Text] [Related]
6. Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki Disease.
Kakisaka Y; Ohara T; Katayama S; Suzuki T; Sasai S; Hino-Fukuyo N; Kure S
Tohoku J Exp Med; 2012 Dec; 228(4):351-3. PubMed ID: 23138414
[TBL] [Abstract][Full Text] [Related]
7. Reaction at the bacillus Calmette--Guérin inoculation site in patients with Kawasaki disease.
Lai CC; Lee PC; Wang CC; Hwang BT; Meng CC; Tsai MC
Pediatr Neonatol; 2013 Feb; 54(1):43-8. PubMed ID: 23445742
[TBL] [Abstract][Full Text] [Related]
8. Analysis of factors associated with development of Bacille Calmette-Guérin inoculation site change in patients with Kawasaki disease.
Araki T; Kodera A; Kitada K; Fujiwara M; Muraoka M; Abe Y; Ikeda M; Tsukahara H
J Int Med Res; 2018 Apr; 46(4):1640-1648. PubMed ID: 29512398
[TBL] [Abstract][Full Text] [Related]
9. Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease.
Novais C; Fortunato F; Bicho A; Preto L
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033285
[TBL] [Abstract][Full Text] [Related]
10. Ulceration at Bacillus Calmette-Guérin Inoculation Site in a Patient with Kawasaki Disease.
Uda K; Hataya H
J Pediatr; 2015 Nov; 167(5):1167-7.e1. PubMed ID: 26342720
[No Abstract] [Full Text] [Related]
11. Disseminated bacille Calmette-Guérin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome.
Bukhari E; Alaklobi F; Bakheet H; Alrabiaah A; Alotibi F; Aljobair F; Alshamrani M; Alaki E; Alnahdi F; Alodyani A; Alzamil F
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3696-702. PubMed ID: 27649674
[TBL] [Abstract][Full Text] [Related]
12. Papulonecrotic tuberculid-like eruptions after Bacille Calmette-Guerin vaccination.
Takada T; Yamashita T; Sato M; Kawakami Y; Tominaga A; Ono I; Jimbow M; Tsutsumi H; Jimbow K
J Dermatol; 2007 Mar; 34(3):183-8. PubMed ID: 17291299
[TBL] [Abstract][Full Text] [Related]
13. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease.
Kuniyuki S; Asada M
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):303-4. PubMed ID: 9270532
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Kawasaki disease before and after universal Bacille Calmette-Guérin vaccination program was discontinued.
Pasma H; Honkila M; Pokka T; Renko M; Salo E; Tapiainen T
Acta Paediatr; 2020 Apr; 109(4):842-846. PubMed ID: 31520428
[TBL] [Abstract][Full Text] [Related]
15. Image Gallery: Severe combined immunodeficiency presenting with disseminated bacille Calmette-Guérin.
Xu CC; Chen H; Sun JF
Br J Dermatol; 2018 Nov; 179(5):e194. PubMed ID: 30387515
[No Abstract] [Full Text] [Related]
16. Bacille Calmette-Guérin inoculation site changes and cardiac complications in patients with Kawasaki disease.
Takikawa H; Ae R; Matsubara Y; Matsubara D; Makino N; Kosami K; Kuwabara M; Sasahara T; Nakamura Y
Arch Dis Child; 2021 Jul; 106(7):669-673. PubMed ID: 33303488
[TBL] [Abstract][Full Text] [Related]
17. Kawasaki disease in children with Bacillus Calmette-Guérin scar reactivity: Focus on coronary outcomes.
Yang MC; Wu KL; Huang CN; Liu YC; Chien YH; Fu CM; Lim HK; Chin CY; Wu JR; Liu HM; Sun LC; Lee CY; Su YH; Wang YF; Lin MT
J Formos Med Assoc; 2023 Oct; 122(10):1001-1007. PubMed ID: 37142476
[TBL] [Abstract][Full Text] [Related]
18. Reaction of the BCG Scar in the Acute Phase of Kawasaki Disease in Mexican Children.
Garrido-García LM; Castillo-Moguel A; Vázquez-Rivera M; Cravioto P; Fernando G
Pediatr Infect Dis J; 2017 Oct; 36(10):e237-e241. PubMed ID: 28498302
[TBL] [Abstract][Full Text] [Related]
19. Serious adverse events associated with bacille Calmette-Guérin vaccine in Canada.
Deeks SL; Clark M; Scheifele DW; Law BJ; Dawar M; Ahmadipour N; Walop W; Ellis CE; King A
Pediatr Infect Dis J; 2005 Jun; 24(6):538-41. PubMed ID: 15933565
[TBL] [Abstract][Full Text] [Related]
20. Management and outcome of Bacille Calmette-Guérin vaccine adverse reactions.
Venkataraman A; Yusuff M; Liebeschuetz S; Riddell A; Prendergast AJ
Vaccine; 2015 Oct; 33(41):5470-5474. PubMed ID: 26275478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
